HPAchina user On December 5, Mengniu Yuerui, in collaboration with Peking University Health Science Center, unveiled its new product, “An Tang Dun.” This product is designed to address the needs of people managing blood sugar levels, leveraging “3210” technology: 3 patented plant extracts, 2 probiotic strains, 1 dietary fiber blend, and 0 sugar with a low glycemic … Read more
On December 2, Melatonin Brain Platinum announced the establishment of its coffee lab located within the Giant Network Park. The lab has already developed classic Brain Platinum coffee, low-caffeine coffee, and innovative drinks such as Ginseng Americano and Probiotic Latte. Alongside the lab’s launch, the first product from the Brain Platinum + Coffee line—Brain Platinum … Read more
On December 3, the General Administration of Customs initiated a public consultation regarding the disposal of unsold inventory under the cross-border e-commerce bonded trade model (customs supervision code 1210). The drafted “Announcement on Clarifying Matters Related to Cross-Border E-Commerce” aims to improve the accuracy of customs statistics, simplify declaration procedures for product destruction or return … Read more
On December 2, the State Administration for Market Regulation (SAMR) released feedback regarding the public consultation for the draft versions of these two documents. A total of 49 emails were received, comprising 191 suggestions. Among these, 50 suggestions were fully adopted, 128 partially adopted, and 13 are pending further research and resolution. The Special Food … Read more
HPA-China Commentary: The article below is from “The Star” online newspaper in Malaysia. Regardless of the accuracy of the claims, it is a cautionary tale of being aware of what your KOL or Influencer in China is saying about your products to get them sold. To drive sales, some influencers streaming live will employee dubious … Read more
Shares of Sirio Pharma rose after the Chinese producer of nutritional health food said it plans to invest no more than USD40 million to build a factory in Thailand to refine its global supply chain and better avoid market risks. Sirio Pharma [SHE: 300791] jumped 4.5 percent to CNY28.15 (USD3.89) apiece as of lunch break … Read more
Sydney-based biotech All G has achieved a world-first in gaining access to the potentially lucrative Chinese market for its synthetic but bioidentical bovine lactoferrin, produced in bioreactors to replicate an immune-bolstering protein that exists in small doses in milk but is abundant in human breast milk. All G claims the regulatory approval breakthrough cements its position … Read more
On November 25, Prof. Slow announced the release of its new Sugar-Control Black Sesame Walnut Powder. Specifically designed for individuals managing blood sugar levels, the product includes nine low-glycemic black ingredients: black sesame, black rice, black beans, black quinoa, chia seeds, mulberries, tartary buckwheat, black oats, and black fungus. Notably, these nine components constitute more … Read more
At the 2024 Tmall Global Pharmaceutical & Health Industry Ecosystem Cooperation Conference held on November 21, Tmall Global reported a significant surge in its health sector during the Double 11 shopping festival. The total GMV and orders achieved double-digit year-over-year growth. Weight management products saw over 200% growth, with categories like calcium-magnesium-zinc supplements, vitamins, and … Read more
On November 22, Meihua Bio announced that its wholly-owned subsidiary in Singapore intends to acquire key assets from Kyowa Hakko Bio Co., Ltd., a subsidiary of Kirin Holdings Company, Limited, for 10.5 billion yen (approximately 68.8 million USD). The acquisition includes food-grade amino acids, pharmaceutical-grade amino acids, and human milk oligosaccharides (HMO) businesses. Post-acquisition, Meihua … Read more
